Literature DB >> 2294941

Lysozyme levels in middle ear effusion and serum in otitis media.

T Harada1, S K Juhn, G L Adams.   

Abstract

Lysozyme concentrations in middle ear effusion and serum were determined in patients with otitis media with effusion. Lysozyme concentrations in middle ear effusion were significantly higher than in serum. Children with mucoid otitis media showed significantly higher levels of lysozyme in middle ear effusion than children with serous otitis media and adults with otitis media with effusion. Higher levels of lysozyme were observed in the group of children younger than 5 years old compared with the age group of 6- to 10-year-olds. Lysozyme concentrations of middle ear effusion in adults were significantly lower than those of mucoid otitis media in children. These results indicate that lysozyme plays an important role in the disease process of otitis media.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2294941     DOI: 10.1001/archotol.1990.01870010058017

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  3 in total

1.  Lysozyme and lactoferrin in human maxillary sinus mucosa during chronic sinusitis. An immunohistochemical study.

Authors:  M Fukami; P Stierna; B Veress; B Carlsöö
Journal:  Eur Arch Otorhinolaryngol       Date:  1993       Impact factor: 2.503

2.  The role of inflammatory mediators in the pathogenesis of otitis media and sequelae.

Authors:  Steven K Juhn; Min-Kyo Jung; Mark D Hoffman; Brian R Drew; Diego A Preciado; Nicholas J Sausen; Timothy T K Jung; Bo Hyung Kim; Sang-Yoo Park; Jizhen Lin; Frank G Ondrey; David R Mains; Tina Huang
Journal:  Clin Exp Otorhinolaryngol       Date:  2008-09-30       Impact factor: 3.372

3.  Antimicrobial activity of innate immune molecules against Streptococcus pneumoniae, Moraxella catarrhalis and nontypeable Haemophilus influenzae.

Authors:  Haa-Yung Lee; Ali Andalibi; Paul Webster; Sung-Kyun Moon; Karen Teufert; Sung-Ho Kang; Jian-Dong Li; Mitsuyoshi Nagura; Tomas Ganz; David J Lim
Journal:  BMC Infect Dis       Date:  2004-05-05       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.